PharmiWeb.com - Global Pharma News & Resources

Medical comms - Press Releases

Date Title Company
01-Jul-2020 New number of shares and votes in Moberg Pharma AB (publ) Moberg Pharma
01-Jul-2020 Genmab Announces Very Favorable Topline Results from Phase 2 Clinical Trial of Tisotumab Vedotin in Recurrent or Metastatic Cervical Cancer Genmab A/S
01-Jul-2020 New contact-tracing app ‘less invasive than Alexa’ The EOSC Secretariat
30-Jun-2020 Registration opens for SMi’s 4th Annual Ophthalmic Drugs Conference SMi Group Ltd
30-Jun-2020 Developing custom syringes for highly viscous formulations to be discussed at the Pre-filled Syringes San Francisco Conference SMi Group Ltd
30-Jun-2020 BioStrata further strengthens specialist life science marketing team with new hires BioStrata
29-Jun-2020 HAND SANITISER SPIKE IS HERE TO STAY, SAYS BCMPA The BCMPA
29-Jun-2020 Celltrion Healthcare Receives Positive CHMP Opinion for an Additional Five Indications for Remsima® SC Including for Use in Inflammatory Bowel Disease and Ankylosing Spondylitis Celltrion Healthcare
29-Jun-2020 Orgenesis Added to Russell 3000(R) Index Orgenesis
29-Jun-2020 HYLORIS PHARMACEUTICALS LISTS ON EURONEXT BRUSSELS Hyloris Pharmaceuticals
29-Jun-2020 Tiziana Life Sciences Announces Agreement with STC Biologics for GMP Manufacturing of an anti-Interleukin-6-Receptor Monoclonal Antibody for Clinical Studies in Patients with COVID-19 Tiziana Life Sciences plc
29-Jun-2020 Sosei Heptares notes Enerzair approval in Japan – the world’s first approval of this novel LABA/LAMA/ICS combination for treating bronchial asthma Sosei Heptares
29-Jun-2020 Nordic Nanovector’s Betalutin® Receives Fast-Track Designation from US FDA for Marginal Zone Lymphoma Nordic Nanovector
29-Jun-2020 Novartis receives positive CHMP opinion for new Xolair® indication to treat severe chronic rhinosinusitis with nasal polyps Novartis
29-Jun-2020 PT010 (budesonide/glycopyrronium/formoterol fumarate) significantly reduced rate of moderate or severe COPD exacerbations vs dual therapies in Phase III ETHOS trial AstraZeneca
29-Jun-2020 Rapid Radiology and OpenText accelerate diagnostic results to help improve patient care Rapid Radiology
29-Jun-2020 JANSSEN EXPRESSES DISAPPOINTMENT WITH NICE FINAL APPRAISAL DOCUMENT DENYING MEN WITH AGGRESSIVE, EARLY PROSTATE CANCER ACCESS TO ZYTIGA® (ABIRATERONE ACETATE) JANSSEN
29-Jun-2020 Successful Elocta (Efmoroctocog alfa) bid means increased access for all people with haemophilia A in the UK SobiTM UK
29-Jun-2020 Berry Global to Supply Medicom in support of British Government’s Mask Manufacturing Mandate Medicom 
29-Jun-2020 Novartis response to NICE Appraisal Consultation Document (ACD) for Mayzent®▼ (siponimod) for the treatment of secondary progressive multiple sclerosis with active disease Novartis